Disc Medicine, Inc. IRON

US Biotechnology

$82.48 ▲ +1.50% (+$1.22)

⬆️ Above Yest. High 🔥 High Short Interest 🎢 High Beta

Open $80.90

Prev Close $81.26

Day Range $80.53 – $83.14

52W Range $40.00 – $99.50

Market Cap $3.70B

Beta 0.92

EPS (TTM) $-6.57

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2020-08-12
Shares Out.	44,350,000
Website	discmedicine.com/ ↗
Phone	13026587581
Employees	165
Revenue	$0
Gross Profit	$0
Net Income	-$59.5M
Free Cash Flow	-$190.0M
Total Assets	$699.5M
Total Liabilities	$95.2M
Equity	$604.3M

About Disc Medicine, Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Disc Medicine, Inc. is a publicly traded company under the ticker symbol IRON on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.